• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于时空控制的基于CRISPR-Cas的基因组调控的光开关gRNA

Photoswitchable gRNAs for Spatiotemporally Controlled CRISPR-Cas-Based Genomic Regulation.

作者信息

Moroz-Omori Elena V, Satyapertiwi Dwiantari, Ramel Marie-Christine, Høgset Håkon, Sunyovszki Ilona K, Liu Ziqian, Wojciechowski Jonathan P, Zhang Yueyun, Grigsby Christopher L, Brito Liliana, Bugeon Laurence, Dallman Margaret J, Stevens Molly M

机构信息

Department of Materials, Department of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London SW7 2AZ, United Kingdom.

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 171 65, Sweden.

出版信息

ACS Cent Sci. 2020 May 27;6(5):695-703. doi: 10.1021/acscentsci.9b01093. Epub 2020 Apr 1.

DOI:10.1021/acscentsci.9b01093
PMID:32490186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256956/
Abstract

The recently discovered CRISPR-Cas gene editing system and its derivatives have found numerous applications in fundamental biology research and pharmaceutical sciences. The need for precise external control over the gene editing and regulatory events has driven the development of inducible CRISPR-Cas systems. While most of the light-controllable CRISPR-Cas systems are based on protein engineering, we developed an alternative synthetic approach based on modification of crRNA/tracrRNA duplex (guide RNA or gRNA) with photocaging groups, preventing the gRNA from recognizing its genome target sequence until its deprotection is induced within seconds of illumination. This approach relies on a straightforward solid-phase synthesis of the photocaged gRNAs, with simpler purification and characterization processes in comparison to engineering a light-responsive protein. We have demonstrated the feasibility of photocaging of gRNAs and light-mediated DNA cleavage upon brief exposure to light . We have achieved light-mediated spatiotemporally resolved gene editing as well as gene activation in cells, whereas photocaged gRNAs showed virtually no detectable gene editing or activation in the absence of light irradiation. Finally, we have applied this system to spatiotemporally control gene editing in zebrafish embryos , enabling the use of this strategy for developmental biology and tissue engineering applications.

摘要

最近发现的CRISPR-Cas基因编辑系统及其衍生物在基础生物学研究和制药科学领域有诸多应用。对基因编辑和调控事件进行精确外部控制的需求推动了可诱导CRISPR-Cas系统的发展。虽然大多数光控CRISPR-Cas系统基于蛋白质工程,但我们开发了一种基于用光笼蔽基团修饰crRNA/tracrRNA双链体(引导RNA或gRNA)的替代合成方法,该方法可防止gRNA识别其基因组靶序列,直至在光照后数秒内诱导其脱保护。这种方法依赖于光笼蔽gRNA的直接固相合成,与工程化光响应蛋白相比,其纯化和表征过程更简单。我们已经证明了gRNA光笼蔽以及短暂光照后光介导的DNA切割的可行性。我们在细胞中实现了光介导的时空分辨基因编辑以及基因激活,而在无光照射的情况下,光笼蔽gRNA几乎没有可检测到的基因编辑或激活。最后,我们将该系统应用于斑马鱼胚胎中的时空控制基因编辑,从而使该策略可用于发育生物学和组织工程应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/48f9b00bb44a/oc9b01093_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/a1f4b3b54d8f/oc9b01093_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/929461053925/oc9b01093_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/7284e2c18acc/oc9b01093_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/48f9b00bb44a/oc9b01093_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/a1f4b3b54d8f/oc9b01093_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/929461053925/oc9b01093_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/7284e2c18acc/oc9b01093_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6352/7256956/48f9b00bb44a/oc9b01093_0004.jpg

相似文献

1
Photoswitchable gRNAs for Spatiotemporally Controlled CRISPR-Cas-Based Genomic Regulation.用于时空控制的基于CRISPR-Cas的基因组调控的光开关gRNA
ACS Cent Sci. 2020 May 27;6(5):695-703. doi: 10.1021/acscentsci.9b01093. Epub 2020 Apr 1.
2
Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.合成引导RNA的最小2'-O-甲基硫代磷酸酯键修饰模式,用于提高稳定性和高效的CRISPR-Cas9基因编辑,避免细胞毒性。
PLoS One. 2017 Nov 27;12(11):e0188593. doi: 10.1371/journal.pone.0188593. eCollection 2017.
3
A Conformational Restriction Strategy for the Control of CRISPR/Cas Gene Editing with Photoactivatable Guide RNAs.一种利用光激活引导RNA控制CRISPR/Cas基因编辑的构象限制策略
Angew Chem Int Ed Engl. 2023 Jan 26;62(5):e202212413. doi: 10.1002/anie.202212413. Epub 2022 Dec 22.
4
Development of a gRNA Expression and Processing Platform for Efficient CRISPR-Cas9-Based Gene Editing and Gene Silencing in Candida tropicalis.开发用于在热带假丝酵母中高效基于 CRISPR-Cas9 的基因编辑和基因沉默的 gRNA 表达和加工平台。
Microbiol Spectr. 2022 Jun 29;10(3):e0005922. doi: 10.1128/spectrum.00059-22. Epub 2022 May 11.
5
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
6
Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light-Activated Guide RNA.利用光激活向导 RNA 在细胞和斑马鱼中对 CRISPR/Cas9 功能进行时空控制。
Angew Chem Int Ed Engl. 2020 Jun 2;59(23):8998-9003. doi: 10.1002/anie.201914575. Epub 2020 Apr 6.
7
Efficient expression of multiple guide RNAs for CRISPR/Cas genome editing.用于CRISPR/Cas基因组编辑的多个引导RNA的高效表达。
aBIOTECH. 2020 Jan 23;1(2):123-134. doi: 10.1007/s42994-019-00014-w. eCollection 2020 Apr.
8
Highly multiplexed genome engineering using CRISPR/Cas9 gRNA arrays.利用 CRISPR/Cas9 gRNA 阵列进行高通量基因组工程。
PLoS One. 2018 Sep 17;13(9):e0198714. doi: 10.1371/journal.pone.0198714. eCollection 2018.
9
Clearance of residual genome editing components used for ex vivo genome-editing of allogeneic cell therapy products.清除用于同种异体细胞治疗产品体外基因组编辑的残留基因组编辑组件。
Cytotherapy. 2024 Nov;26(11):1341-1352. doi: 10.1016/j.jcyt.2024.06.005. Epub 2024 Jul 11.
10
CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.CRISPRseek:一个用于识别CRISPR-Cas9基因组编辑系统中靶点特异性引导RNA的生物导体软件包。
PLoS One. 2014 Sep 23;9(9):e108424. doi: 10.1371/journal.pone.0108424. eCollection 2014.

引用本文的文献

1
Controlling CRISPR-Cas9 genome editing in human cells using a molecular glue degrader.使用分子胶降解剂控制人类细胞中的CRISPR-Cas9基因组编辑。
Mol Ther Nucleic Acids. 2025 Jul 21;36(3):102640. doi: 10.1016/j.omtn.2025.102640. eCollection 2025 Sep 9.
2
Precision Control of Light-Responsive Nucleic Acids Modified with Photoremovable Protecting Groups for Functionalization.用于功能化的、用光可去除保护基团修饰的光响应核酸的精确控制。
JACS Au. 2025 Jun 19;5(7):2953-2976. doi: 10.1021/jacsau.5c00524. eCollection 2025 Jul 28.
3
Light-controlled genome editing by activation of Cas9-mRNA translation.

本文引用的文献

1
Near-infrared upconversion-activated CRISPR-Cas9 system: A remote-controlled gene editing platform.近红外上转换激活的 CRISPR-Cas9 系统:一种远程控制的基因编辑平台。
Sci Adv. 2019 Apr 3;5(4):eaav7199. doi: 10.1126/sciadv.aav7199. eCollection 2019 Apr.
2
Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets.利用纳米磁体实现体内 CRISPR-Cas9 基因组编辑的空间控制。
Nat Biomed Eng. 2019 Feb;3(2):126-136. doi: 10.1038/s41551-018-0318-7. Epub 2018 Nov 12.
3
Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation.
通过激活Cas9 - mRNA翻译实现光控基因组编辑。
Chem Sci. 2025 Jun 30. doi: 10.1039/d5sc01999k.
4
Scalable modulation of CRISPR‒Cas enzyme activity using photocleavable phosphorothioate DNA.使用光可裂解硫代磷酸酯DNA对CRISPR-Cas酶活性进行可扩展调节。
Nat Commun. 2025 Jul 1;16(1):5939. doi: 10.1038/s41467-025-61094-5.
5
Near-infrared light activatable chemically induced CRISPR system.近红外光可激活的化学诱导CRISPR系统
Light Sci Appl. 2025 Jul 1;14(1):229. doi: 10.1038/s41377-025-01917-8.
6
Enhancement of CRISPR-Cas12a system through universal circular RNA design.通过通用环状RNA设计增强CRISPR-Cas12a系统
Cell Rep Methods. 2025 Jun 16;5(6):101076. doi: 10.1016/j.crmeth.2025.101076.
7
Conditional Control of CRISPR/Cas9 Function by Chemically Modified Oligonucleotides.通过化学修饰的寡核苷酸对CRISPR/Cas9功能进行条件控制。
Molecules. 2025 Apr 28;30(9):1956. doi: 10.3390/molecules30091956.
8
Light-Triggered CRISPR/Cas12a for Genomic Editing and Tumor Regression.用于基因组编辑和肿瘤消退的光触发CRISPR/Cas12a
Angew Chem Int Ed Engl. 2025 Jul 7;64(28):e202502892. doi: 10.1002/anie.202502892. Epub 2025 May 19.
9
Optogenetic control of Corynebacterium glutamicum gene expression.谷氨酸棒杆菌基因表达的光遗传学控制
Nucleic Acids Res. 2024 Dec 11;52(22):14260-14276. doi: 10.1093/nar/gkae1149.
10
Development of artificial transcription factors and their applications in cell reprograming, genetic screen, and disease treatment.人工转录因子的开发及其在细胞重编程、基因筛选和疾病治疗中的应用。
Mol Ther. 2024 Dec 4;32(12):4208-4234. doi: 10.1016/j.ymthe.2024.10.029. Epub 2024 Oct 28.
通过自我限制 Cas9 转录和翻译来最小化 CRISPR 脱靶效应的合成开关。
Nucleic Acids Res. 2019 Feb 20;47(3):e13. doi: 10.1093/nar/gky1165.
4
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy.基因编辑恢复了杜氏肌营养不良犬模型中的肌营养不良蛋白表达。
Science. 2018 Oct 5;362(6410):86-91. doi: 10.1126/science.aau1549. Epub 2018 Aug 30.
5
Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation.合成远红光介导的 CRISPR-dCas9 装置诱导功能性神经元分化。
Proc Natl Acad Sci U S A. 2018 Jul 17;115(29):E6722-E6730. doi: 10.1073/pnas.1802448115. Epub 2018 Jul 2.
6
CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.CRISPR/Cas9 系统靶向 HIV-1 的调节基因,抑制感染 T 细胞培养物中的病毒复制。
Sci Rep. 2018 May 17;8(1):7784. doi: 10.1038/s41598-018-26190-1.
7
Chimeric Guides Probe and Enhance Cas9 Biochemical Activity.嵌合向导探针可探测并增强Cas9的生化活性。
Biochemistry. 2018 May 29;57(21):3027-3031. doi: 10.1021/acs.biochem.8b00107. Epub 2018 May 14.
8
Gene therapy clinical trials worldwide to 2017: An update.基因治疗临床试验全球更新至 2017 年
J Gene Med. 2018 May;20(5):e3015. doi: 10.1002/jgm.3015. Epub 2018 Apr 19.
9
Rewiring Calcium Signaling for Precise Transcriptional Reprogramming.重新连接钙信号以实现精确的转录重编程
ACS Synth Biol. 2018 Mar 16;7(3):814-821. doi: 10.1021/acssynbio.7b00467. Epub 2018 Mar 6.
10
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.一种用于治疗 T 细胞血液系统恶性肿瘤的现成型抗自杀 CAR-T。
Leukemia. 2018 Sep;32(9):1970-1983. doi: 10.1038/s41375-018-0065-5. Epub 2018 Feb 20.